Rigel has enrolled the first subject in a Phase I trial of its oral spleen tyrosine kinase (SYK) inhibitor, fostamatinib, to ...

Rigel Pharmaceuticals (RIGL) announced the first patient has been enrolled in a Phase 1 study evaluating the safety and tolerability of ...

Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced the first patient has been enrolled in a Phase 1 study evaluating ...

Let’s keep our hearts strong by giving the gift of life. Donating blood is quick, easy and can save lives. Your donation makes a real difference as every drop counts.

Humans and mice exposed to long-wavelength red light had lower rates of blood clots that can cause heart attacks, lung damage and strokes, according to research led by surgeon-scientists.

A new investigation published by The BMJ highlights fresh concerns about the PLATO clinical trial, a pivotal study that led to the global approval of the anti-platelet drug ticagrelor (marketed as ...

Most human cases of bird flu in North America have been mild, a fact that’s underscored by a new study of the first 46 confirmed human H5N1 infections in the United States this year. But the ...